Pharmaceutical manufacturing index jumps by 45.6% in Ryazan region

| By | Drug Manufacturing, FORT
2388

In H1 2017, the manufacturing index of medicinal products and materials used for medical purposes increased by 45.6% in the Ryazan region compared to the same period of 2016, announced Ryazanstat, a state statistical department.

Ryazan region has two major pharmaceutical production facilities.

FORT is a national biopharmaceutical company engaged in the development, manufacturing and promotion of innovative immunobiological medicinal products. It manufactures vaccines against seasonal and pandemic flu, antiviral vaccines, and recombinant pharmaceutical proteins.

LLC SKOPINPHARM is a modern dynamically developing Russian pharmaceutical company that manufactures medicinal products. The product portfolio of SCOPINPHARM includes 15 drugs (for the treatment of the gastrointestinal tract, antimicrobial and antiretroviral medicines, etc.)